{
  "company": {
    "name": "Aeovian Pharmaceuticals",
    "website": "https://aeovian.com/",
    "record": "https://startuphistory.org/c/aeovian.com"
  },
  "status": null,
  "history_since": "2020-08-15T19:17:38.000Z",
  "baseline": {
    "snapshot_id": "fc9c7d4f7a8a7a7c37bcd9c4826e31933a69966f80815f87a0af2bacabbbc11a",
    "observed_at": "2020-08-15T19:17:38.000Z",
    "headline": "Aeovian Pharmaceuticals Inc.",
    "description": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
    "evidence": "https://web.archive.org/web/20200815191738/https://www.aeovian.com/",
    "evidence_kind": "internet_archive",
    "facts": {
      "version": 1,
      "pages": [
        {
          "page": "home",
          "customers": [],
          "investors": [],
          "prices": [],
          "compliance": [],
          "funding": [
            "He actively participated in Series A financing that raised $20 million with prominent venture capital firms."
          ]
        }
      ]
    },
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T14:15:24.513Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2023-10-03T10:18:24.000Z",
      "variants": [
        {
          "headline": "Aeovian Pharmaceuticals Inc.",
          "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
          "observed_at": "2020-08-15T19:17:38.000Z",
          "evidence": "https://web.archive.org/web/20200815191738/https://www.aeovian.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Aeovian Pharmaceuticals Inc.",
          "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
          "observed_at": "2021-08-06T02:57:05.000Z",
          "evidence": "https://web.archive.org/web/20210806025705/https://www.aeovian.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Aeovian Pharmaceuticals Inc.",
          "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
          "observed_at": "2022-01-24T06:30:05.000Z",
          "evidence": "https://web.archive.org/web/20220124063005/https://www.aeovian.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Aeovian Pharmaceuticals Inc.",
          "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
          "observed_at": "2023-02-05T13:46:06.000Z",
          "evidence": "https://web.archive.org/web/20230205134606/https://www.aeovian.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Aeovian Pharmaceuticals Inc.",
          "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
          "observed_at": "2023-10-03T10:18:24.000Z",
          "evidence": "https://web.archive.org/web/20231003101824/https://www.aeovian.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Aeovian Pharmaceuticals Inc.",
      "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
      "from": "2020-08-15T19:17:38.000Z",
      "to": "2023-10-03T10:18:24.000Z",
      "captures": 5,
      "evidence": "https://web.archive.org/web/20231003101824/https://www.aeovian.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2020-08-15T19:17:38.000Z",
          "to": "2023-10-03T10:18:24.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2025-01-07T00:32:04.000Z",
      "variants": [
        {
          "headline": "March 28, 2024",
          "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
          "observed_at": "2024-07-01T17:45:54.000Z",
          "evidence": "https://web.archive.org/web/20240701174554/https://www.aeovian.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "March 28, 2024",
          "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
          "observed_at": "2025-01-07T00:32:04.000Z",
          "evidence": "https://web.archive.org/web/20250107003204/https://www.aeovian.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "March 28, 2024",
      "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
      "from": "2024-07-01T17:45:54.000Z",
      "to": "2025-01-07T00:32:04.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20250107003204/https://www.aeovian.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2024-07-01T17:45:54.000Z",
          "to": "2025-01-07T00:32:04.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T14:15:24.513Z",
      "variants": [
        {
          "headline": "Science & Pipeline",
          "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
          "observed_at": "2026-01-19T11:18:01.000Z",
          "evidence": "https://web.archive.org/web/20260119111801/https://www.aeovian.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Science & Pipeline",
          "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
          "observed_at": "2026-04-22T17:27:41.000Z",
          "evidence": "https://web.archive.org/web/20260422172741/https://www.aeovian.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Science & Pipeline",
          "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
          "observed_at": "2026-07-12T17:56:48.000Z",
          "evidence": "https://web.archive.org/web/20260712175648/https://www.aeovian.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Science & Pipeline",
          "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
          "observed_at": "2026-10-16T00:37:44.000Z",
          "evidence": "https://web.archive.org/web/20261016003744/https://www.aeovian.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Science & Pipeline",
          "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
          "observed_at": "2026-11-06T14:15:24.513Z",
          "evidence": "https://www.aeovian.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Science & Pipeline",
      "subhead": "Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.",
      "from": "2026-01-19T11:18:01.000Z",
      "to": "2026-11-06T14:15:24.513Z",
      "captures": 5,
      "evidence": "https://www.aeovian.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-01-19T11:18:01.000Z",
          "to": "2026-11-06T14:15:24.513Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-24414e3e629f388705dad202d68643392b9f9c550ebb6f2d03e466da3a14f1c3:91e631f173b99607717d3d78bdcf83382f211ddab8b72ed7067a3ebb14582712:headline:8c7ff03edf8f5cb6",
      "before_evidence": "https://web.archive.org/web/20250107003204/https://www.aeovian.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “March 28, 2024” to “Science & Pipeline”.",
      "between": {
        "from": "2025-01-07T00:32:04.000Z",
        "to": "2026-01-19T11:18:01.000Z"
      },
      "evidence": "https://web.archive.org/web/20260119111801/https://www.aeovian.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Aeovian Pharmaceuticals” company record, https://startuphistory.org/c/aeovian.com"
}